Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin's lymphoma

Journal of Clinical Oncology

Volumn 28, Issue 5, 2010, Pages 793-799

  Al Mansour, Mubarak ^a   Connors, Joseph M ^a   Gascoyne, Randy D ^a   Skinnider, Brian ^a   Savage, Kerry J ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL FEATURE; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; AGED; BIOPSY; CANADA; CANCER INVASION; DATA BASE; DISEASE COURSE; DISEASE FREE SURVIVAL; FOLLICULAR LYMPHOMA; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; SECOND CANCER; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BIOPSY; BRITISH COLUMBIA; DATABASES AS TOPIC; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASMS, SECOND PRIMARY; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77649215824     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.24.9516     Document Type: Article

References (36)

1. Harris NL, Jaffe ES, Stein H, et al: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994 (Pubitemid 24273002)
2. Diehl V, Sextro M, Franklin J, et al: Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: Report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease. J Clin Oncol 17:776-783, 1999 (Pubitemid 29109305)
3. Russell KJ, Hoppe RT, Colby TV, et al: Lymphocyte predominant Hodgkin's disease: Clinical presentation and results of treatment. Radiother Oncol 1:197-205, 1984
4. Swerdlow SH, Campo E, Harris NL, et al: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue (ed 4). Geneva, Switzerland, WHO, 2008
5. Marafioti T, Hummel M, Anagnostopoulos I, et al: Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. N Engl J Med 337:453-458, 1997 (Pubitemid 27333046)
6. Hansmann ML, Zwingers T, Boske A, et al: Clinical features of nodular paragranuloma (Hodgkin's disease, lymphocyte predominance type, nodular). J Cancer Res Clin Oncol 108:321-330, 1984 (Pubitemid 15211812)
7. Bennett MH, MacLennan KA, Vaughan Hudson G, et al: Non-Hodgkin's lymphoma arising in patients treated for Hodgkin's disease in the BNLI: A 20-year experience-British National Lymphoma Investigation. Ann Oncol 2:83-92, 1991 (suppl 2)
8. Chittal SM, Alard C, Rossi JF, et al: Further phenotypic evidence that nodular, lymphocyte-predominant Hodgkin's disease is a large B-cell lymphoma in evolution. Am J Surg Pathol 14:1024-1035, 1990 (Pubitemid 20360708)
9. Hansmann ML, Stein H, Fellbaum C, et al: Nodular paragranuloma can transform into highgrade malignant lymphoma of B type. Hum Pathol 20:1169-1175, 1989 (Pubitemid 20034146)
10. Miettinen M, Franssila KO, Saxen E: Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas. Cancer 51:2293-2300, 1983
11. Huang JZ, Weisenburger DD, Vose JM, et al: Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: A report of 21 cases from the Nebraska Lymphoma Study Group. Leuk Lymphoma 45:1551-1557, 2004
12. Orlandi E, Lazzarino M, Brusamolino E, et al: Nodular lymphocyte predominance Hodgkin's disease: Long-term observation reveals a continuous pattern of recurrence. Leuk Lymphoma 26:359-368, 1997 (Pubitemid 27401920)
13. Jaffe ES, Zarate-Osorno A, Kingma DW, et al: The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas. Ann Oncol 5:7-11, 1994 (suppl) (Pubitemid 24051308)
14. Wickert RS, Weisenburger DD, Tierens A, et al: Clonal relationship between lymphocytic predominance Hodgkin's disease and concurrent or subsequent large-cell lymphoma of B lineage. Blood 86: 2312-2320, 1995
15. Hell K, Hansmann ML, Pringle JH, et al: Combination of Hodgkin's disease and diffuse large cell lymphoma: An in situ hybridization study for immunoglobulin light chain messenger RNA. Histopathology 27:491-499, 1995 (Pubitemid 26024214)
16. Greiner TC, Gascoyne RD, Anderson ME, et al: Nodular lymphocyte- predominant Hodgkin's disease associated with large-cell lymphoma: Analysis of Ig gene rearrangements by V-J polymerase chain reaction. Blood 88:657-666, 1996
17. Sundeen JT, Cossman J, Jaffe ES: Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent "large cell lymphoma": Histological progression or composite malignancy? Am J Surg Pathol 12:599-606, 1988
18. Grossman DM, Hanson CA, Schnitzer B: Simultaneous lymphocyte predominant Hodgkin's disease and large-cell lymphoma. Am J Surg Pathol 15:668-676, 1991
19. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
20. Connors JM, Klimo P, Adams G, et al: Treatment of advanced Hodgkin's disease with chemotherapy: Comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD-A report from the National Cancer Institute of Canada clinical trials group. J Clin Oncol 15:1638-1645, 1997 (Pubitemid 27167404)
21. Macpherson N, Klasa RJ, Gascoyne R, et al: Treatment of elderly Hodgkin's lymphoma patients with a novel 5-drug regimen (ODBEP): A phase II study. Leuk Lymphoma 43:1395-1402, 2002
22. O'Reilly SE, Hoskins P, Klimo P, et al: MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's disease. Ann Oncol 2:17-23, 1991 (suppl 1)
23. Baetz T, Belch A, Couban S, et al: Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: A phase II study by the National Cancer Institute of Canada Clinical Trials Group. Ann Oncol 14:1762-1767, 2003
24. Moskowitz CH, Bertino JR, Glassman JR, et al: Ifosfamide, carboplatin, and etoposide: A highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma. J Clin Oncol 17:3776-3785, 1999
25. Anagnostopoulos I, Hansmann ML, Franssila K, et al: European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: Histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood 96:1889-1899, 2000
26. Diehl V, Franklin J, Sextro M, et al: Clinical presentation and treatment of lymphocyte predominance Hodgkin's disease, in Armitage JO, Diehl V, Hoppe RT, et al (eds): Hodgkin's Disease. Philadelphia, PA, Lippincott Williams & Wilkins, 1999, pp 563-582
27. Nogova L, Reineke T, Josting A, et al: Lymphocyte-predominant and classical Hodgkin's lymphoma: Comparison of outcomes. Eur J Haematol 66:106-110, 2005 (suppl)
28. Bodis S, Kraus MD, Pinkus G, et al: Clinical presentation and outcome in lymphocyte predominant Hodgkin's disease. J Clin Oncol 15:3060-3066, 1997
29. Boudová L, Torlakovic E, Delabie J, et al: Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma. Blood 102: 3753-3758, 2003
30. Cazals-Hatem D, Lepage E, Brice P, et al: Primary mediastinal large B-cell lymphoma: A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study. Am J Surg Pathol 20:877-888, 1996
31. Al-Tourah AJ, Gill KK, Chhanabhai M, et al: Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma. J Clin Oncol 26:5165-5169, 2008
32. Coiffier B, Lepage E, Briere J, et al: CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346:235-242, 2002
33. Rueffer U, Josting A, Franklin J, et al: Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: Incidence, treatment, and prognosis. J Clin Oncol 19:2026-2032, 2001
34. Ekstrand BC, Horning SJ: Lymphocyte predominant Hodgkin's disease. Curr Oncol Rep 4:424-433, 2002
35. Rudiger T, Gascoyne RD, Jaffe ES, et al: Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma. Ann Oncol 13: 44-51, 2002 (suppl 1)
36. Torlakovic E, Tierens A, Dang HD, et al: The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease. Am J Pathol 159:1807-1814, 2001